Areca nut extract may be a potentially driving force for tumors to become autophagy addicted

Mei-Huei Lin1, Young-Chau Liu2, Chang-Ta Chiu3

  • 1Department of Life and Health Science, Chia Nan University of Pharmacy & Science, Tainan, Taiwan.

PubMed

Insights

Areca nut extract (ANE) components induce autophagy, increasing tumor cell tolerance. Inhibiting this autophagy shows promise for treating tumors in areca nut users.

Area of Science:

  • Cellular Biology
  • Oncology
  • Pharmacology

Background:

  • Areca nut (AN) contains autophagy-inducing ingredients (ANE 30-100K).
  • Previous studies showed ANE/ANE 30-100K induce tolerance to environmental stress and accelerate tumor growth via upregulated autophagy.
  • Autophagy-stimulated tumor cells exhibit sensitivity to autophagy inhibition.

Purpose of the Study:

  • To investigate the efficacy of autophagy blockade in areca nut-stimulated tumors.
  • To evaluate the role of ATG5 in autophagy-dependent tumor growth.
  • To assess the resistance of non-stimulated cells to autophagy inhibition.

Main Methods:

  • Utilized atg5 shRNA to inhibit autophagy in stimulated CE81T/VGH cells in mice.
  • Administered 3-methyladenine (3-MA), an autophagy inhibitor, to non-stimulated control cells in mice.

Main Results:

  • atg5 shRNA significantly inhibited the growth of autophagy-stimulated CE81T/VGH cells in mice.
  • Non-stimulated control cells demonstrated resistance to 3-MA treatment.
  • Findings confirm the critical role of autophagy in the proliferation of ANE-stimulated tumor cells.

Conclusions:

  • Autophagy blockade is a potential therapeutic strategy for tumors associated with areca nut consumption.
  • Targeting autophagy may be particularly effective in patients with a history of areca nut use.
  • Further research into autophagy-dependent tumor vulnerabilities is warranted.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K